Press Releases

“Animal Connections” Rolls in to Washington, D.C.  Oct. 26-29 From the cows that provide the milk for a bowl of cereal to the deer nibbling on a shrub in the park, from sea lions working with their trainers at the zoo to puppies chasing balls in the yard, the connections humans have with animals are vast. This special relationship is explored in a new mobile exhibit from the Smithsonian. “Animal Connections: Our Journey Together,” a custom-built exhibition housed on an 18-wheel truck that expands into 1,000 square feet of space, will be on view on the National Mall between the Smithsonian Castle and the Smithsonian’s National Museum of Natural History Saturday, Oct. 26, through Monday, Oct. 28, before moving to a location near the U.S. Botanic Garden Tuesday, Oct. 29. The free exhibition will be open daily from 10 a.m. to 4 p.m.  For the safety of animals and people, visitors are asked not to bring pets. “The affection that people everywhere have for animals sparked our enthusiasm for ...

Zoetis Offers a Targeted Approach that Rapidly, Sustainably and Safely Breaks the Cycle of Itch and Inflammation Associated with Allergic Skin Diseases in Dogs FLORHAM PARK, N.J. – September 19, 2013 – Zoetis, Inc. (NYSE: ZTS), formerly the animal health business unit of Pfizer Inc., today announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has approved APOQUEL ® (oclacitinib tablet) in the European Union for the treatment of pruritus associated with allergic dermatitis and the treatment of clinical manifestations of atopic dermatitis in dogs at least 12 months of age. Developed by Zoetis, APOQUEL ® is the first Janus kinase (JAK) inhibitor approved for veterinary use. It inhibits the function of a variety of allergic, itch and pro-inflammatory cytokines dependent on JAK enzyme activity and thus stops the cycle of itch and inflammation occurring in skin allergies. APOQUEL ® provides rapid and ...

“Animal Connections” Rolls in to Newark’s Prudential Center August 19-21 and Morristown’s Fosterfields September 8 NEWARK, N.J. August 16, 2013 —From the cows that provide the milk for a bowl of cereal to the deer nibbling on a shrub in the park, from sea lions working with their trainers at the zoo to puppies chasing balls in the yard, the connections humans have with animals are vast. This special relationship is explored in a new mobile exhibition from the Smithsonian. “Animal Connections: Our Journey Together,” a custom-built exhibition housed on an 18-wheel truck that expands into 1,000 square feet of space, will be at the Prudential Center in Newark August 19 through August 21, and at the 1920s Country Fair and Harvest Festival at Fosterfields Living Historical Farm in Morristown on September 8.The exhibition is an introduction to the world of veterinary medicine and was developed to inspire future generations of veterinary professionals.  This free exhibition explores the ...

Researchers to examine the effects of animal-assisted therapy on pediatric oncology patients, their primary caregivers, and therapy dogs at two major children’s hospitals across the country WASHINGTON, D.C. – Help for the more than 12,000 children diagnosed with cancer each year in the United States, in the form of an innovative, four-legged therapy, is about to be rigorously studied to determine its efficacy. Zoetis Inc., a global leader in the advancement of animal health and wellness, and American Humane Association, which since 1877 has been the nation’s leading charity dedicated to the  welfare, wellness and well-being of children and animals, and to unleashing the full potential of the bond between humans and animals to the mutual benefit of both, are announcing the beginning of the pilot trial at sites in Florida and Tennessee of a groundbreaking  research study on the effects of animal-assisted therapy on pediatric oncology patients and their families. The Canines and ...

Comprehensive eCommerce website creates personal shopping experience for veterinary professionals Finding time in a hectic veterinary practice to order animal health products from Zoetis just became faster and easier, thanks to a new web-based ordering site that offers customers in the United States 24/7 access to more than 300 product lines that support the health of beef and dairy cattle, poultry, pigs, dogs, cats, horses and sheep. The new eCommerce site ( www.zoetisus.com click on SHOP)—the industry’s most robust and personalized web-based ordering system of its kind—features a personalized home page that creates a seamless interaction between Zoetis and its customers, displaying recent order history, product preferences, and promotions specific to the user’s practice. “Customers can still expect the same level of interaction and support from their Zoetis representative. However, the eCommerce site will now provide the added convenience of 24/7 online access to help our customers ...

Zoetis Offers a Targeted New Approach to Rapidly and Safely Stop the Cycle of Itch and Inflammation Associated with Allergic Skin Disease in Dogs Zoetis, Inc. (NYSE: ZTS), formerly the animal health business unit of Pfizer Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved APOQUEL® (oclacitinib tablet) for the control of pruritus associated with allergic dermatitis and the control of atopic dermatitis in dogs at least 12 months of age. Pruritus, or itching, is the most common sign of allergies in dogs. Developed by Zoetis, APOQUEL is the first Janus kinase (JAK) inhibitor approved for veterinary use that targets the itch and inflammation pathway. APOQUEL provides fast-acting relief from itching and improves inflammation for the estimated 8.2 million dogs that suffer from short- and long-term allergic skin conditions. “Previously available treatments have helped with the management of allergic skin disease in dogs, but an unmet need still exists for a ...

Two awards presented to support research in otitis and atopic dermatitis Zoetis Inc., formerly the animal health business unit of Pfizer Inc., today announced the first recipients of the company’s Excellence in Dermatology™ Research Grant program. The objective of the new program is to support research in the area of basic science diagnosing and treating dermatologic conditions in dogs and cats. Investigators from the University of Pennsylvania and Johns Hopkins University will receive one grant to pursue collaborative research in Pseudomonas otitis in dogs. A second grant is being awarded to a team at the University of Minnesota to study the potential for a new drug target in atopic dermatitis. “Zoetis is committed to the advancement of clinical science and the improvement of care in the field of companion animal dermatology,” said J. Michael McFarland, DVM, DABVP and group director of Companion Animal Veterinary Operations for Zoetis. “We are pleased to support these research ...

Product Features Advanced Sensitivity ZoetisTM, formerly the animal health business unit of Pfizer Inc., today announced the U.S. Department of Agriculture (USDA) has approved a newly-enhanced version of the WITNESS® HW Heartworm Antigen Test kit for dogs and cats. Launched today, the enhanced WITNESS HW test kit is now available to veterinarians nationwide. Enhancements to the biologics, including test antibodies, improvements to the buffer and sample pad and improve the signal strength at the control line for better confidence in the results, translates to improved sensitivity in the convenient, affordable and versatile test. “Veterinarians have depended on WITNESS HW since its introduction in 1997,” said J. Michael McFarland, DVM, DABVP and group director of Companion Animal Veterinary Operations for Zoetis. “The enhanced version of this trusted product provides veterinarians with accurate, easy to interpret results in approximately ten minutes so they can begin heartworm ...